Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), and End User (Hospitals) - Global Forecast to 2023
“High global prevalence of cancer is expected to drive the overall growth of the cell surface markers market”
The cell surface markers market is projected to reach USD 769 million by 2023 from USD 520 million in 2018, at a CAGR of 8.1% during the forecast period. The growth of this market is majorly driven by the high global prevalence of cancer, increasing funding for life sciences research, and growth in stem cell and neurobiology research. On the other hand, factors such as the costly and time-intensive antibody development process may hinder the growth of this market in the coming years.
“Antibodies segment is expected to grow at the highest CAGR during the forecast period”
Based on product type, the cell surface markers market is segmented into antibodies and PCR arrays. The antibodies segment is expected to account for a larger share of the market in 2018 as well as grow at a higher CAGR during the forecast period. This can majorly be attributed to the increasing demand for accurate and reliable antibodies by research communities.
“T cell surface markers segment is expected to account for the largest share of the cell surface markers market, by cell type, during the forecast period”
Based on cell type, the cell surface markers market is segmented into T cell surface markers, B cell surface markers, NK cell surface markers, monocyte cell surface markers, and other cell types. In 2018, the T cell surface markers segment is expected to account for the largest share of the cell surface markers market. The large share of this segment is attributed to the high and growing use of T cell surface markers in research and diagnostics.
“North America to dominate the market during the forecast period”
In 2018, North America is expected to account for the largest share of the cell surface markers market. North America has a well-established pharmaceuticals sector and currently dominates the cell surface markers market due to the increasing demand for the effective diagnosis and treatment of chronic diseases. Also, the adoption rate of cell surface markers for disease diagnostics, majorly for cancer diagnosis, is high in North America. This is one of the major factors supporting the growth of this regional market. The Asian market, on the other hand, is expected to grow at the highest CAGR during the forecast period. Factors such as government initiatives to boost biotechnology and pharmaceutical industries and increasing life sciences research activities are supporting the growth of the cell surface markers market in Asia.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the global cell surface markers market. It aims at estimating the size and future growth potential of the market across different segments, such as product type, antibodies by source, cell type, application, end user, and region. The report also includes an in-depth competitive analysis of key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them the closest approximations of the revenue numbers for the overall cell surface markers market and its subsegments. Also, this report will help stakeholders to better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.
The cell surface markers market is projected to reach USD 769 million by 2023 from USD 520 million in 2018, at a CAGR of 8.1% during the forecast period. The growth of this market is majorly driven by the high global prevalence of cancer, increasing funding for life sciences research, and growth in stem cell and neurobiology research. On the other hand, factors such as the costly and time-intensive antibody development process may hinder the growth of this market in the coming years.
“Antibodies segment is expected to grow at the highest CAGR during the forecast period”
Based on product type, the cell surface markers market is segmented into antibodies and PCR arrays. The antibodies segment is expected to account for a larger share of the market in 2018 as well as grow at a higher CAGR during the forecast period. This can majorly be attributed to the increasing demand for accurate and reliable antibodies by research communities.
“T cell surface markers segment is expected to account for the largest share of the cell surface markers market, by cell type, during the forecast period”
Based on cell type, the cell surface markers market is segmented into T cell surface markers, B cell surface markers, NK cell surface markers, monocyte cell surface markers, and other cell types. In 2018, the T cell surface markers segment is expected to account for the largest share of the cell surface markers market. The large share of this segment is attributed to the high and growing use of T cell surface markers in research and diagnostics.
“North America to dominate the market during the forecast period”
In 2018, North America is expected to account for the largest share of the cell surface markers market. North America has a well-established pharmaceuticals sector and currently dominates the cell surface markers market due to the increasing demand for the effective diagnosis and treatment of chronic diseases. Also, the adoption rate of cell surface markers for disease diagnostics, majorly for cancer diagnosis, is high in North America. This is one of the major factors supporting the growth of this regional market. The Asian market, on the other hand, is expected to grow at the highest CAGR during the forecast period. Factors such as government initiatives to boost biotechnology and pharmaceutical industries and increasing life sciences research activities are supporting the growth of the cell surface markers market in Asia.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type - Tier 1: 55%, Tier 2: 20%, Tier 3: 25%
- By Designation - C-level: 58%, D-level: 19%, Others: 23%
- By Region - North America: 40%, Europe: 30%, Asia: 10%, RoW: 20%
- Thermo Fisher Scientific (US)
- QIAGEN N.V. (Netherlands)
- Becton, Dickinson and Company (US)
- F. Hoffman-La Roche (Switzerland)
- Bio-Rad Laboratories (US)
- Danaher Corporation (US)
- Abcam (UK)
- Genscript (China)
- Biolegend (US)
- B. Braun Melsungen AG (Germany)
- Cell Signaling Technology (US)
- Merck KGaA (Germany)
- Bio-Techne (US)
This report provides a detailed picture of the global cell surface markers market. It aims at estimating the size and future growth potential of the market across different segments, such as product type, antibodies by source, cell type, application, end user, and region. The report also includes an in-depth competitive analysis of key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them the closest approximations of the revenue numbers for the overall cell surface markers market and its subsegments. Also, this report will help stakeholders to better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CELL SURFACE MARKERS: MARKET OVERVIEW
4.2 CELL SURFACE MARKERS MARKET, BY PRODUCT
4.3 CELL SURFACE MARKERS MARKET, BY CELL TYPE (2018)
4.4 CELL SURFACE MARKERS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
4.5 CELL SURFACE MARKERS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
4.6 CELL SURFACE MARKERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing funding for life science research
5.2.1.2 High global prevalence of cancer
5.2.1.3 Growth in stem cell and neurobiology research
5.2.2 RESTRAINTS
5.2.2.1 Costly and time-intensive antibody development process
5.2.3 OPPORTUNITIES
5.2.3.1 High growth opportunities in emerging markets
6 CELL SURFACE MARKERS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ANTIBODIES
6.2.1 ANTIBODIES TO DOMINATE THE CELL SURFACE MARKER PRODUCTS MARKET DURING THE FORECAST PERIOD
6.3 PCR ARRAYS
6.3.1 PCR ARRAY PROFILES THE EXPRESSION OF GENES RELEVANT TO RESEARCH AT THE CELL SURFACE MARKER LEVEL
7 CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE
7.1 INTRODUCTION
7.2 MICE
7.2.1 MICE ARE THE MOST PREFERRED HOSTS FOR RESEARCH-USE CELL SURFACE ANTIBODY PRODUCTION
7.3 RATS
7.3.1 RATS ARE THE SECOND-MOST-WIDELY USED ANIMAL HOSTS FOR MONOCLONAL ANTIBODY PRODUCTION
7.4 OTHER SOURCES
8 CELL SURFACE MARKERS MARKET, BY CELL TYPE
8.1 INTRODUCTION
8.2 T CELL SURFACE MARKERS
8.2.1 T CELL SURFACE MARKERS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018
8.3 B CELL SURFACE MARKERS
8.3.1 B CELL SURFACE MARKERS ARE USED TO IDENTIFY B CELLS FROM HETEROGENEOUS SAMPLES
8.4 NK CELL SURFACE MARKERS
8.4.1 NK CELL SURFACE MARKERS IDENTIFY NK CELLS AT VARIOUS STAGES OF DEVELOPMENT
8.5 MONOCYTE CELL SURFACE MARKERS
8.5.1 MONOCYTES PLAY A CRITICAL ROLE IN MAINTAINING OVERALL HEALTH
8.6 OTHER CELL TYPES
9 CELL SURFACE MARKERS MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 RESEARCH APPLICATIONS
9.2.1 DRUG DISCOVERY
9.2.1.1 Cell surface markers play an important role in guiding decisions in every phase of drug development
9.2.2 IMMUNOLOGY
9.2.2.1 The assessment of cell surface antigens using cell surface markers is an important field of immunological research
9.2.3 STEM CELL RESEARCH
9.2.3.1 Cell surface biomarkers are used to characterize, isolate, and analyze stem cells
9.2.4 OTHER RESEARCH APPLICATIONS
9.3 CLINICAL APPLICATIONS
9.3.1 ONCOLOGY
9.3.1.1 Cell surface markers are an emerging diagnostic tool in the field of hematological oncology.
9.3.2 IMMUNODEFICIENCY DISEASES
9.3.2.1 Cell surface markers are used for the detection of HIV infections
9.3.3 OTHER CLINICAL APPLICATIONS
10 CELL SURFACE MARKERS MARKET, BY END USER
10.1 INTRODUCTION
10.2 ACADEMIC & RESEARCH INSTITUTES
10.2.1 ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS OF THE CELL SURFACE MARKERS MARKET
10.3 HOSPITALS & CLINICAL TESTING LABORATORIES
10.3.1 HOSPITALS & CLINICAL TESTING LABORATORIES USE CELL SURFACE MARKERS FOR THE DIAGNOSIS OF VARIOUS DISEASES
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.4.1 PATENT EXPIRATION OF BLOCKBUSTER DRUGS TO DRIVE THE GROWTH OF THE CELL MARKERS MARKET FOR THIS END-USER SEGMENT
11 CELL SURFACE MARKERS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 High prevalence of chronic diseases
11.2.1.2 Favorable funding for precision medicine research activities
11.2.2 CANADA
11.2.2.1 Availability of research funding
11.2.2.2 Increasing prevalence of cancer
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Availability of funding driving the number of research activities
11.3.1.2 Large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers
11.3.2 FRANCE
11.3.2.1 Presence of a large biotechnology industry
11.3.2.2 Government initiatives to boost research and development activities
11.3.3 UK
11.3.3.1 Government initiatives to strengthen academic research
11.3.3.2 Increasing incidence and prevalence of chronic and infectious diseases
11.3.4 ROE
11.4 ASIA
11.5 ROW
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET RANKING ANALYSIS
12.3 COMPETITIVE SCENARIO
12.3.1 PARTNERSHIPS AND AGREEMENTS (2016–2018)
12.3.2 PRODUCT LAUNCHES (2016–2018)
12.3.3 ACQUISITIONS (2016–2018)
12.3.4 EXPANSIONS (2016–2018)
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 THERMO FISHER SCIENTIFIC
13.2 BECTON, DICKINSON AND COMPANY
13.3 ABCAM
13.4 QIAGEN N.V.
13.5 F. HOFFMAN-LA ROCHE
13.6 BIO-RAD LABORATORIES
13.7 DANAHER CORPORATION
13.8 GENSCRIPT
13.9 BIOLEGEND
13.10 CELL SIGNALING TECHNOLOGY
13.11 BIO-TECHNE
13.12 MERK KGAA
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CELL SURFACE MARKERS: MARKET OVERVIEW
4.2 CELL SURFACE MARKERS MARKET, BY PRODUCT
4.3 CELL SURFACE MARKERS MARKET, BY CELL TYPE (2018)
4.4 CELL SURFACE MARKERS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
4.5 CELL SURFACE MARKERS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
4.6 CELL SURFACE MARKERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing funding for life science research
5.2.1.2 High global prevalence of cancer
5.2.1.3 Growth in stem cell and neurobiology research
5.2.2 RESTRAINTS
5.2.2.1 Costly and time-intensive antibody development process
5.2.3 OPPORTUNITIES
5.2.3.1 High growth opportunities in emerging markets
6 CELL SURFACE MARKERS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ANTIBODIES
6.2.1 ANTIBODIES TO DOMINATE THE CELL SURFACE MARKER PRODUCTS MARKET DURING THE FORECAST PERIOD
6.3 PCR ARRAYS
6.3.1 PCR ARRAY PROFILES THE EXPRESSION OF GENES RELEVANT TO RESEARCH AT THE CELL SURFACE MARKER LEVEL
7 CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE
7.1 INTRODUCTION
7.2 MICE
7.2.1 MICE ARE THE MOST PREFERRED HOSTS FOR RESEARCH-USE CELL SURFACE ANTIBODY PRODUCTION
7.3 RATS
7.3.1 RATS ARE THE SECOND-MOST-WIDELY USED ANIMAL HOSTS FOR MONOCLONAL ANTIBODY PRODUCTION
7.4 OTHER SOURCES
8 CELL SURFACE MARKERS MARKET, BY CELL TYPE
8.1 INTRODUCTION
8.2 T CELL SURFACE MARKERS
8.2.1 T CELL SURFACE MARKERS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018
8.3 B CELL SURFACE MARKERS
8.3.1 B CELL SURFACE MARKERS ARE USED TO IDENTIFY B CELLS FROM HETEROGENEOUS SAMPLES
8.4 NK CELL SURFACE MARKERS
8.4.1 NK CELL SURFACE MARKERS IDENTIFY NK CELLS AT VARIOUS STAGES OF DEVELOPMENT
8.5 MONOCYTE CELL SURFACE MARKERS
8.5.1 MONOCYTES PLAY A CRITICAL ROLE IN MAINTAINING OVERALL HEALTH
8.6 OTHER CELL TYPES
9 CELL SURFACE MARKERS MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 RESEARCH APPLICATIONS
9.2.1 DRUG DISCOVERY
9.2.1.1 Cell surface markers play an important role in guiding decisions in every phase of drug development
9.2.2 IMMUNOLOGY
9.2.2.1 The assessment of cell surface antigens using cell surface markers is an important field of immunological research
9.2.3 STEM CELL RESEARCH
9.2.3.1 Cell surface biomarkers are used to characterize, isolate, and analyze stem cells
9.2.4 OTHER RESEARCH APPLICATIONS
9.3 CLINICAL APPLICATIONS
9.3.1 ONCOLOGY
9.3.1.1 Cell surface markers are an emerging diagnostic tool in the field of hematological oncology.
9.3.2 IMMUNODEFICIENCY DISEASES
9.3.2.1 Cell surface markers are used for the detection of HIV infections
9.3.3 OTHER CLINICAL APPLICATIONS
10 CELL SURFACE MARKERS MARKET, BY END USER
10.1 INTRODUCTION
10.2 ACADEMIC & RESEARCH INSTITUTES
10.2.1 ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS OF THE CELL SURFACE MARKERS MARKET
10.3 HOSPITALS & CLINICAL TESTING LABORATORIES
10.3.1 HOSPITALS & CLINICAL TESTING LABORATORIES USE CELL SURFACE MARKERS FOR THE DIAGNOSIS OF VARIOUS DISEASES
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.4.1 PATENT EXPIRATION OF BLOCKBUSTER DRUGS TO DRIVE THE GROWTH OF THE CELL MARKERS MARKET FOR THIS END-USER SEGMENT
11 CELL SURFACE MARKERS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 High prevalence of chronic diseases
11.2.1.2 Favorable funding for precision medicine research activities
11.2.2 CANADA
11.2.2.1 Availability of research funding
11.2.2.2 Increasing prevalence of cancer
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Availability of funding driving the number of research activities
11.3.1.2 Large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers
11.3.2 FRANCE
11.3.2.1 Presence of a large biotechnology industry
11.3.2.2 Government initiatives to boost research and development activities
11.3.3 UK
11.3.3.1 Government initiatives to strengthen academic research
11.3.3.2 Increasing incidence and prevalence of chronic and infectious diseases
11.3.4 ROE
11.4 ASIA
11.5 ROW
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET RANKING ANALYSIS
12.3 COMPETITIVE SCENARIO
12.3.1 PARTNERSHIPS AND AGREEMENTS (2016–2018)
12.3.2 PRODUCT LAUNCHES (2016–2018)
12.3.3 ACQUISITIONS (2016–2018)
12.3.4 EXPANSIONS (2016–2018)
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 THERMO FISHER SCIENTIFIC
13.2 BECTON, DICKINSON AND COMPANY
13.3 ABCAM
13.4 QIAGEN N.V.
13.5 F. HOFFMAN-LA ROCHE
13.6 BIO-RAD LABORATORIES
13.7 DANAHER CORPORATION
13.8 GENSCRIPT
13.9 BIOLEGEND
13.10 CELL SIGNALING TECHNOLOGY
13.11 BIO-TECHNE
13.12 MERK KGAA
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
LIST OF TABLES
Table 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
Table 2 CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 3 CELL SURFACE MARKER ANTIBODIES MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 4 CELL SURFACE MARKER PCR ARRAYS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 5 CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 6 CELL SURFACE MARKER ANTIBODIES MARKET FOR MICE, BY REGION, 2016–2023 (USD MILLION)
Table 7 CELL SURFACE MARKER ANTIBODIES MARKET FOR RATS, BY REGION, 2016–2023 (USD MILLION)
Table 8 CELL SURFACE MARKER ANTIBODIES MARKET FOR OTHER SOURCES, BY REGION, 2016–2023 (USD MILLION)
Table 9 CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 10 T CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 11 B CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 12 NK CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 13 MONOCYTE CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 14 CELL SURFACE MARKERS MARKET FOR OTHER CELL TYPES, BY REGION, 2016–2023 (USD MILLION)
Table 15 CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 16 CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 17 CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 18 CELL SURFACE MARKERS MARKET FOR DRUG DISCOVERY, BY REGION, 2016–2023 (USD MILLION)
Table 19 CELL SURFACE MARKERS MARKET FOR IMMUNOLOGY, BY REGION, 2016–2023 (USD MILLION)
Table 20 CELL SURFACE MARKERS MARKET FOR STEM CELL RESEARCH, BY REGION, 2016–2023 (USD MILLION)
Table 21 CELL SURFACE MARKERS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 22 CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 23 CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 24 CELL SURFACE MARKERS MARKET FOR ONCOLOGY, BY REGION, 2016–2023 (USD MILLION)
Table 25 CELL SURFACE MARKERS MARKET FOR IMMUNODEFICIENCY DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 26 CELL SURFACE MARKERS MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 27 CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 28 CELL SURFACE MARKERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016–2023 (USD MILLION)
Table 29 CELL SURFACE MARKERS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2016–2023 (USD MILLION)
Table 30 CELL SURFACE MARKERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION)
Table 31 CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 32 NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 33 NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 34 NORTH AMERICA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 35 NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 36 NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 37 NORTH AMERICA: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 38 NORTH AMERICA: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 39 NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 40 US: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 41 US: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 42 US: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 43 US: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 44 US: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 45 CANADA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 46 CANADA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 47 CANADA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 48 CANADA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 49 CANADA: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 50 EUROPE: CELL SURFACE MARKERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 51 EUROPE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 52 EUROPE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 53 EUROPE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 54 EUROPE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 55 EUROPE: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 56 EUROPE: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 57 EUROPE: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 58 GERMANY: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 59 GERMANY: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 60 GERMANY: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 61 GERMANY: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 62 GERMANY: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 63 FRANCE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 64 FRANCE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 65 FRANCE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 66 FRANCE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 67 FRANCE: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 68 UK: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 69 UK: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 70 UK: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 71 UK: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 72 UK: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 73 ROE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 74 ROE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 75 ROE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 76 ROE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 77 ROE: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 78 ASIA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 79 ASIA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 80 ASIA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 81 ASIA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 82 ASIA: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 83 ASIA: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 84 ASIA: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 85 ROW: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 86 ROW: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 87 ROW: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 88 ROW: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 89 ROW: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 90 ROW: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 91 ROW: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
Table 2 CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 3 CELL SURFACE MARKER ANTIBODIES MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 4 CELL SURFACE MARKER PCR ARRAYS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 5 CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 6 CELL SURFACE MARKER ANTIBODIES MARKET FOR MICE, BY REGION, 2016–2023 (USD MILLION)
Table 7 CELL SURFACE MARKER ANTIBODIES MARKET FOR RATS, BY REGION, 2016–2023 (USD MILLION)
Table 8 CELL SURFACE MARKER ANTIBODIES MARKET FOR OTHER SOURCES, BY REGION, 2016–2023 (USD MILLION)
Table 9 CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 10 T CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 11 B CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 12 NK CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 13 MONOCYTE CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 14 CELL SURFACE MARKERS MARKET FOR OTHER CELL TYPES, BY REGION, 2016–2023 (USD MILLION)
Table 15 CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 16 CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 17 CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 18 CELL SURFACE MARKERS MARKET FOR DRUG DISCOVERY, BY REGION, 2016–2023 (USD MILLION)
Table 19 CELL SURFACE MARKERS MARKET FOR IMMUNOLOGY, BY REGION, 2016–2023 (USD MILLION)
Table 20 CELL SURFACE MARKERS MARKET FOR STEM CELL RESEARCH, BY REGION, 2016–2023 (USD MILLION)
Table 21 CELL SURFACE MARKERS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 22 CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 23 CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 24 CELL SURFACE MARKERS MARKET FOR ONCOLOGY, BY REGION, 2016–2023 (USD MILLION)
Table 25 CELL SURFACE MARKERS MARKET FOR IMMUNODEFICIENCY DISEASES, BY REGION, 2016–2023 (USD MILLION)
Table 26 CELL SURFACE MARKERS MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
Table 27 CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 28 CELL SURFACE MARKERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016–2023 (USD MILLION)
Table 29 CELL SURFACE MARKERS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2016–2023 (USD MILLION)
Table 30 CELL SURFACE MARKERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION)
Table 31 CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 32 NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 33 NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 34 NORTH AMERICA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 35 NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 36 NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 37 NORTH AMERICA: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 38 NORTH AMERICA: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 39 NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 40 US: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 41 US: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 42 US: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 43 US: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 44 US: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 45 CANADA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 46 CANADA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 47 CANADA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 48 CANADA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 49 CANADA: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 50 EUROPE: CELL SURFACE MARKERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 51 EUROPE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 52 EUROPE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 53 EUROPE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 54 EUROPE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 55 EUROPE: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 56 EUROPE: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 57 EUROPE: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 58 GERMANY: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 59 GERMANY: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 60 GERMANY: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 61 GERMANY: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 62 GERMANY: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 63 FRANCE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 64 FRANCE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 65 FRANCE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 66 FRANCE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 67 FRANCE: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 68 UK: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 69 UK: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 70 UK: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 71 UK: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 72 UK: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 73 ROE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 74 ROE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 75 ROE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 76 ROE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 77 ROE: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 78 ASIA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 79 ASIA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 80 ASIA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 81 ASIA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 82 ASIA: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 83 ASIA: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 84 ASIA: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 85 ROW: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 86 ROW: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
Table 87 ROW: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
Table 88 ROW: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 89 ROW: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 90 ROW: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
Table 91 ROW: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
LIST OF FIGURES
Figure 1 CELL SURFACE MARKER MARKET SEGMENTATION
Figure 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 CELL SURFACE MARKERS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
Figure 7 CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE
Figure 8 CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2018 VS. 2023 (USD MILLION)
Figure 9 CELL SURFACE MARKERS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
Figure 10 CELL SURFACE MARKERS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
Figure 11 GEOGRAPHICAL SNAPSHOT OF THE CELL SURFACE MARKERS MARKET
Figure 12 HIGH GLOBAL BURDEN OF CANCER & INCREASING FUNDING FOR LIFE SCIENCE RESEARCH ARE DRIVING THE GROWTH OF THE CELL SURFACE MARKERS MARKET
Figure 13 ANTIBODIES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 14 T CELL SURFACE MARKERS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018
Figure 15 CLINICAL APPLICATIONS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 16 ACADEMIC & RESEARCH INSTITUTES SEGMENT TO DOMINATE THE CELL SURFACE MARKERS MARKET DURING THE FORECAST PERIOD
Figure 17 ASIA IS THE FASTEST-GROWING REGION IN THE CELL SURFACE MARKERS MARKET
Figure 18 CELL SURFACE MARKERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
Figure 19 ANTIBODIES SEGMENT WILL CONTINUE TO DOMINATE THE CELL SURFACE MARKER PRODUCTS MARKET DURING THE FORECAST PERIOD
Figure 20 MICE SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE CELL SURFACE MARKER ANTIBODIES MARKET DURING THE FORECAST PERIOD
Figure 21 T CELL SURFACE MARKERS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
Figure 22 RESEARCH APPLICATIONS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL SURFACE MARKERS MARKET IN 2018
Figure 23 HOSPITALS & CLINICAL TESTING LABORATORIES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 24 NORTH AMERICA: CELL SURFACE MARKERS MARKET SNAPSHOT
Figure 25 EUROPE: CELL SURFACE MARKERS MARKET SNAPSHOT
Figure 26 ASIA: CELL SURFACE MARKERS MARKET SNAPSHOT
Figure 27 ROW: CELL SURFACE MARKERS MARKET SNAPSHOT
Figure 28 KEY DEVELOPMENTS IN THE CELL SURFACE MARKERS MARKET (JAN 2016-NOV 2018)
Figure 29 MARKET EVOLUTION FRAMEWORK
Figure 30 CELL SURFACE MARKERS MARKET RANKING ANALYSIS, BY KEY PLAYER (2017)
Figure 31 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC (2017)
Figure 32 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
Figure 33 COMPANY SNAPSHOT: ABCAM (2018*)
Figure 34 COMPANY SNAPSHOT: QIAGEN N.V. (2017)
Figure 35 COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE AG (2017)
Figure 36 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2017)
Figure 37 COMPANY SNAPSHOT: DANAHER CORPORATION (2017)
Figure 38 COMPANY SNAPSHOT: GENSCRIPT (2017)
Figure 39 COMPANY SNAPSHOT: BIO-TECHNE (2017)
Figure 40 COMPANY SNAPSHOT: MERCK KGAA (2017)
Figure 1 CELL SURFACE MARKER MARKET SEGMENTATION
Figure 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 CELL SURFACE MARKERS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
Figure 7 CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE
Figure 8 CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2018 VS. 2023 (USD MILLION)
Figure 9 CELL SURFACE MARKERS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
Figure 10 CELL SURFACE MARKERS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
Figure 11 GEOGRAPHICAL SNAPSHOT OF THE CELL SURFACE MARKERS MARKET
Figure 12 HIGH GLOBAL BURDEN OF CANCER & INCREASING FUNDING FOR LIFE SCIENCE RESEARCH ARE DRIVING THE GROWTH OF THE CELL SURFACE MARKERS MARKET
Figure 13 ANTIBODIES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 14 T CELL SURFACE MARKERS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018
Figure 15 CLINICAL APPLICATIONS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 16 ACADEMIC & RESEARCH INSTITUTES SEGMENT TO DOMINATE THE CELL SURFACE MARKERS MARKET DURING THE FORECAST PERIOD
Figure 17 ASIA IS THE FASTEST-GROWING REGION IN THE CELL SURFACE MARKERS MARKET
Figure 18 CELL SURFACE MARKERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
Figure 19 ANTIBODIES SEGMENT WILL CONTINUE TO DOMINATE THE CELL SURFACE MARKER PRODUCTS MARKET DURING THE FORECAST PERIOD
Figure 20 MICE SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE CELL SURFACE MARKER ANTIBODIES MARKET DURING THE FORECAST PERIOD
Figure 21 T CELL SURFACE MARKERS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
Figure 22 RESEARCH APPLICATIONS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL SURFACE MARKERS MARKET IN 2018
Figure 23 HOSPITALS & CLINICAL TESTING LABORATORIES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 24 NORTH AMERICA: CELL SURFACE MARKERS MARKET SNAPSHOT
Figure 25 EUROPE: CELL SURFACE MARKERS MARKET SNAPSHOT
Figure 26 ASIA: CELL SURFACE MARKERS MARKET SNAPSHOT
Figure 27 ROW: CELL SURFACE MARKERS MARKET SNAPSHOT
Figure 28 KEY DEVELOPMENTS IN THE CELL SURFACE MARKERS MARKET (JAN 2016-NOV 2018)
Figure 29 MARKET EVOLUTION FRAMEWORK
Figure 30 CELL SURFACE MARKERS MARKET RANKING ANALYSIS, BY KEY PLAYER (2017)
Figure 31 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC (2017)
Figure 32 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
Figure 33 COMPANY SNAPSHOT: ABCAM (2018*)
Figure 34 COMPANY SNAPSHOT: QIAGEN N.V. (2017)
Figure 35 COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE AG (2017)
Figure 36 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2017)
Figure 37 COMPANY SNAPSHOT: DANAHER CORPORATION (2017)
Figure 38 COMPANY SNAPSHOT: GENSCRIPT (2017)
Figure 39 COMPANY SNAPSHOT: BIO-TECHNE (2017)
Figure 40 COMPANY SNAPSHOT: MERCK KGAA (2017)
